The effect of supplementation of omega-3 and zinc on the treatment of type 2 diabetes

Phase 3

• Conditions: Type 2 diabetes.; Diabetes mellitus

• Registration Number: IRCT20180201038585N1
• Lead Sponsor: Bagheiat-allah University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 March 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Adults with Type 2 Diabetes

Exclusion Criteria

Insulin injection
Pregnancy and lactation
Pancreatic cancer

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Alanine aminotransferase. Timepoint: At weeks 0, 8. Method of measurement: Enzymatic method-IU/Lit.;Aspartate aminotransferase. Timepoint: At weeks 0, 8. Method of measurement: Enzymatic method-IU/Lit.;Gamma glutamyl transpeptidase. Timepoint: At weeks 0, 8. Method of measurement: Enzymatic method-IU/Lit.;Alkaline phosphatase. Timepoint: At weeks 0, 8. Method of measurement: Enzymatic method-IU/Lit.;Creatinine. Timepoint: At weeks 0, 8. Method of measurement: Enzymatic method, mg/dl.;Uric acid. Timepoint: At weeks 0, 8. Method of measurement: Enzymatic method, mg/dl.;Urea. Timepoint: At weeks 0, 8. Method of measurement: Enzymatic method, mg/dl.